Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

By Bayraktar Soley  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 145-153

Springer Publishing Company

Access to resources Recommend Favorite

Two founder BRCA2 mutations predispose to breast cancer in young women

By Infante Mar  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 567-571

Springer Publishing Company

Access to resources Recommend Favorite

Novel Germline BRCA1 and BRCA2 Mutations in Turkish Women with Breast and/or Ovarian Cancer and Their Relatives

By Egeli Unal   Cecener Gulsah   Tunca Berrin   Tasdelen Ismet  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 484-491

Informa Healthcare

Access to resources Recommend Favorite

Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

By Gershoni-Baruch R.   Dagan E.   Fried G.   Bruchim Bar-Sade R.   Sverdlov-Shiri R.   Zelicksson G.   Friedman E.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 983-986

Elsevier

Access to resources Recommend Favorite

Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women

By Comen E.   Davids M.   Kirchhoff T.   Hudis C.   Offit K.   Robson M.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite